Biomarin Pharmaceutical Inc (BMRN)
Biomarin Pharmaceutical Inc (BMRN) is a Healthcare stock tracked by StreetAlpha. BMRN reports earnings on Mon, Oct 26, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 10 firms (9 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in BMRN, 0% of them bullish and 100% bearish.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 20 | JP Morgan | Maintained | Buy | — |
| Oct 15 | UBS | Assumed coverage | Buy | — |
| Oct 14 | Barclays | Target raised | Buy | — |
| Sep 1 | Piper Sandler | Target raised | Buy | — |
| Aug 31 | Jefferies | Maintained | Buy | — |
Whale Options Flow
90DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BMRN is in one of them and how their past BMRN trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered BMRN in an article yet. Here's the latest on the wider market.
BMRN Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Dan GoldmanD · NY | Sell | $1K – $15K | Mar 6, 2023 | Apr 17, 2023 | 42 d |
| Ro KhannaD · CA | Sell | $1K – $15K | Mar 14, 2023 | Apr 7, 2023 | 24 d |
| Ro KhannaD · CA | Buy | $1K – $15K | Dec 6, 2022 | Jan 3, 2023 | 28 d |
| Ro KhannaD · CA | Sell | $1K – $15K | May 10, 2022 | Jun 10, 2022 | 31 d |
| Josh GottheimerD · NJ | Sell | $1K – $15K | Oct 18, 2021 | Nov 15, 2021 | 28 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.